Background: Urinary calprotectin has recently been identified as a promising biomarker for the differentiation between prerenal and intrinsic acute kidney injury (AKI) in the nontransplant population. The present study investigates whether calprotectin is able to differentiate between these 2 entities in transplant recipients as well.
Methods: Urinary calprotectin was assessed by enzyme-linked immunosorbent assay in 328 subjects including 125 cases of intrinsic acute allograft failure, 27 prerenal graft failures, 118 patients with stable graft function, and 58 healthy controls. Acute graft failure was defined as AKI stages 1 to 3 (Acute Kidney Injury Network criteria), exclusion criteria were obstructive uropathy, urothelial carcinoma, and metastatic cancer. The clinical differentiation of prerenal and intrinsic graft failure was performed either by biopsy or by a clinical algorithm including response to fluid repletion, history, physical examination, and urine dipstick examination.
Results: Reasons for intrinsic graft failure comprised rejection, acute tubular necrosis, urinary tract infection/pyelonephritis, viral nephritis, and interstitial nephritis. Calprotectin concentrations of patients with stable graft function (50.4 ng/mL) were comparable to healthy controls (54.8 ng/mL, P = 0.70) and prerenal graft failure (53.8 ng/mL, P = 0.62). Median urinary calprotectin was 36 times higher in intrinsic AKI (1955 ng/mL) than in prerenal AKI (P < 0.001). Receiver-operating characteristic curve analysis revealed a high accuracy of calprotectin (area under the curve, 0.94) in the differentiation of intrinsic versus prerenal AKI. A cutoff level of 134.5 ng/mL provided a sensitivity of 90.4% and a specificity of 74.1%. Immunohistochemical stainings for calprotectin in renal allograft biopsy specimens confirmed the serological results.
Conclusions: Urinary calprotectin is a promising biomarker for the differentiation of prerenal and intrinsic acute renal allograft failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/TP.0000000000001124 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploratory study on reference intervals of calprotectin and pentraxin 3.
Ann Clin Biochem
December 2024
Department of Global Medical and Clinical Affairs, Greiner Bio-One, Kremsmünster, Austria.
Introduction: The aim of our study was to determine reference intervals for serum pentraxin 3 and calprotectin, as well as for urine calprotectin according to the CLSI EP28-A3C guidelines for defining, establishing, and verifying reference intervals in the clinical laboratory.
Materials And Methods: A total of 120 serum and urine samples from either healthy volunteers or outpatients were used for reference interval establishment. The participants had CRP levels, leucocyte counts, serum urea levels, creatinine levels, and estimated glomerular filtration rates (CKD-EPI eGFRs) within the reference range and no medical history of acute/chronic inflammatory diseases/conditions or cancer.
Assessment of urine calprotectin and YKL-40 levels in urinary tract infection diagnosis in children under 2 years of age.
Sci Rep
November 2024
Department of Paediatrics, Paediatric Nephrology and Allergology, Military Institute of Medicine - National Research Institute, 128 Szaserow Str, 04-141, Warsaw, Poland.
Article Synopsis
- * This study involved 67 children aged 1 month to 2 years, dividing them into three groups: those with febrile UTIs, those with fever from other causes, and healthy controls.
- * Results showed significantly higher levels of calprotectin and YKL-40 in urine from the UTI group compared to the other groups, indicating these markers could help diagnose febrile UTIs in children effectively.
Trivalent immunization with metal-binding proteins confers protection against enterococci in a mouse infection model.
FEMS Microbes
October 2024
Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, FL 32610, United States.
is ranked among the top five bacterial pathogens responsible for catheter-associated urinary tract infections, wound infections, secondary root canal infections, and infective endocarditis. Previously, we showed that inactivation of either the manganese- and iron-binding (EfaA) or zinc-binding (AdcA and AdcAII) lipoproteins significantly reduced virulence. Here, we explored whether immunization using a multi-valent approach induces protective immunity against systemic enterococcal infections.
View Article and Find Full Text PDFFecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn's Disease.
Inflamm Bowel Dis
November 2024
Department of Paediatrics, University of Otago, Christchurch, New Zealand.
Background: Crohn's disease (CD) is a major form of inflammatory bowel disease (IBD) which has relapsing and remitting symptoms. Better ways to detect and monitor active disease are required for early diagnosis and optimal outcomes. We assessed fecal myeloperoxidase (fMPO), a neutrophil-derived enzyme that produces hypochlorous acid, as a marker of disease activity in children with CD.
View Article and Find Full Text PDFNew Markers of Early Kidney Damage in Children and Adolescents with Simple Obesity.
Int J Mol Sci
October 2024
Clinical Department of Paediatric Nephrology, Wroclaw Medical University, 50-367 Wrocław, Poland.
The impact of obesity on kidney injury and the development of chronic kidney disease (CKD) is well documented. Unfortunately, the early stages of CKD are asymptomatic, leading to a delayed diagnosis and a worse prognosis. There is a need for more sensitive indicators of kidney damage than those currently used.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!